搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosopumilus maritimus UPF0218 protein Nmar_1233 (Nmar_1233) CSB-YP427859NFB
CSB-EP427859NFB
CSB-BP427859NFB
CSB-MP427859NFB
CSB-EP427859NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus tRNA pseudouridine synthase Pus10 (pus10) CSB-YP427860NFB
CSB-EP427860NFB
CSB-BP427860NFB
CSB-MP427860NFB
CSB-EP427860NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus Shikimate dehydrogenase (aroE) CSB-YP427861NFB
CSB-EP427861NFB
CSB-BP427861NFB
CSB-MP427861NFB
CSB-EP427861NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus Threonine--tRNA ligase (thrS), partial CSB-YP427862NFB
CSB-EP427862NFB
CSB-BP427862NFB
CSB-MP427862NFB
CSB-EP427862NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP427863NFB
CSB-EP427863NFB
CSB-BP427863NFB
CSB-MP427863NFB
CSB-EP427863NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP427864NFB
CSB-EP427864NFB
CSB-BP427864NFB
CSB-MP427864NFB
CSB-EP427864NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosopumilus maritimus UPF0103 protein Nmar_0215 (Nmar_0215) CSB-YP427865NFB
CSB-EP427865NFB
CSB-BP427865NFB
CSB-MP427865NFB
CSB-EP427865NFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola Ribonuclease Z (rnz) CSB-YP427866STC
CSB-EP427866STC
CSB-BP427866STC
CSB-MP427866STC
CSB-EP427866STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola Chaperone protein htpG (htpG), partial CSB-YP427867STC
CSB-EP427867STC
CSB-BP427867STC
CSB-MP427867STC
CSB-EP427867STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola 30S ribosomal protein S13 (rpsM) CSB-YP427868STC
CSB-EP427868STC
CSB-BP427868STC
CSB-MP427868STC
CSB-EP427868STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola 30S ribosomal protein S10 (rpsJ) CSB-YP427869STC
CSB-EP427869STC
CSB-BP427869STC
CSB-MP427869STC
CSB-EP427869STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP427870STC
CSB-EP427870STC
CSB-BP427870STC
CSB-MP427870STC
CSB-EP427870STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola NADH-quinone oxidoreductase subunit B 2 (nuoB2) CSB-YP427871STC
CSB-EP427871STC
CSB-BP427871STC
CSB-MP427871STC
CSB-EP427871STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola UPF0102 protein Sare_1228 (Sare_1228) CSB-YP427872STC
CSB-EP427872STC
CSB-BP427872STC
CSB-MP427872STC
CSB-EP427872STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola 50S ribosomal protein L33 1 (rpmG1) CSB-YP427873STC
CSB-EP427873STC
CSB-BP427873STC
CSB-MP427873STC
CSB-EP427873STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola Ribosomal protein S12 methylthiotransferase RimO (rimO), partial CSB-YP427874STC
CSB-EP427874STC
CSB-BP427874STC
CSB-MP427874STC
CSB-EP427874STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB, partial CSB-YP427875STC
CSB-EP427875STC
CSB-BP427875STC
CSB-MP427875STC
CSB-EP427875STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salinispora arenicola Aspartate 1-decarboxylase (panD) CSB-YP427876STC
CSB-EP427876STC
CSB-BP427876STC
CSB-MP427876STC
CSB-EP427876STC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis N-acetyl-gamma-glutamyl-phosphate/N-acetyl-gamma-aminoadipyl-phosphate reductase (argC) CSB-YP427877CVY
CSB-EP427877CVY
CSB-BP427877CVY
CSB-MP427877CVY
CSB-EP427877CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caldivirga maquilingensis 50S ribosomal protein L18P (rpl18p) CSB-YP427878CVY
CSB-EP427878CVY
CSB-BP427878CVY
CSB-MP427878CVY
CSB-EP427878CVY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>